SCHEDULE: Biomea Fusion Insider Stake Drops to 5.2%

Rainer M. Erdtmann and affiliated entities report a decrease in beneficial ownership of Biomea Fusion, Inc. common stock to 5.2%.

Summary

• Rainer M. Erdtmann, along with Point Sur Investors, LLC and Point Sur Investors Fund I, L.P., collectively reported beneficial ownership of 5.2% of Biomea Fusion, Inc.'s common stock as of June 30, 2025.
• Rainer M. Erdtmann individually beneficially owns 2,975,224 shares, representing 5.2% of the class.
• This ownership includes 2,494,434 shares with sole voting and dispositive power, and 480,790 shares with shared voting and dispositive power.
• Erdtmann's beneficial ownership comprises 482,404 shares from exercisable stock options, 643,027 directly held shares, 59,400 shares held by his children, 174,614 shares in Trust 1, and 1,134,989 shares in Trust 2.
• Point Sur Investors, LLC directly holds 252,320 shares, representing 0.8% of the class, with sole voting and dispositive power over 480,790 shares.
• Point Sur Investors Fund I, L.P. directly holds 228,470 shares, representing 0.4% of the class, with sole voting and dispositive power over 228,470 shares.
• Point Sur LLC is the General Partner of Point Sur Investors Fund, and Rainer M. Erdtmann is a managing member of Point Sur LLC, granting him shared voting and dispositive power over shares held by both entities.
• The percentage of class is based on 57,022,250 shares outstanding as of the completion of a recent offering, plus 482,404 shares issuable from options within 60 days.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the reported decrease in beneficial ownership percentage by a key insider and affiliated entities, which can sometimes be interpreted as a reduction in confidence or a strategic portfolio adjustment.

Negatives

• The beneficial ownership percentage for Rainer M. Erdtmann decreased from 6.2% (as reported in Amendment No. 2 for the event date December 31, 2024) to 5.2% (as reported in this Amendment No. 3 for the event date June 30, 2025), indicating a reduction in insider stake.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of beneficial ownership changes by a significant shareholder and affiliated entities, common in the biotechnology or pharmaceutical industry for publicly traded companies. It does not provide broader industry trends but reflects an individual's and associated funds' investment position in Biomea Fusion, Inc.

Stakeholder Impact

• Shareholders: The decrease in beneficial ownership by a significant insider may influence investor sentiment regarding the company's stock.

Key Dates

Recommendation

The filing indicates a decrease in beneficial ownership by a significant insider, Rainer M. Erdtmann, from 6.2% to 5.2%. While this is a notable change, a Schedule 13G filing primarily reports ownership status and does not provide operational or financial performance details. Without additional context on the reasons for the reduction (e.g., portfolio rebalancing, liquidity needs, or a change in outlook), a 'hold' recommendation is prudent. Investors should monitor future filings and company performance for further insights before making a definitive buy or sell decision.

Keywords

Biomea Fusion, Rainer M. Erdtmann, Point Sur Investors, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Insider Ownership, Equity Stake